IH
PDLI

IFC Holdings’s PDL BioPharma, Inc. PDLI Stock Holding History

IFC Holdings’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-17,202
Closed -$35K – 486
2016
Q4 		$35K Buy
17,202
+7,000
+69% +$19.5K ﹤0.01% 418
2016
Q3 		$34K Buy
+10,202
New +$32.4K ﹤0.01% 404

Other funds holding PDLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IFC Holdings's PDLI Position: Q1 2017 in Review

IFC Holdings sold out of PDL BioPharma, Inc. (PDLI) in Q1 2017, closing a stake of 17,202 shares — an estimated $35K sold.

IFC Holdings first reported a position in PDLI in Q3 2016 and held it in 2 quarters. The position peaked at $35K in Q4 2016. 174 funds tracked by Wall St. Rank hold PDLI as of Q1 2017.

  • IFC Holdings reported no remaining PDL BioPharma, Inc. position as of Q1 2017 after selling out during the quarter.
  • IFC Holdings sold 17,202 PDL BioPharma, Inc. shares in Q1 2017, an estimated $35K.
  • IFC Holdings first reported a position in PDL BioPharma, Inc. in Q3 2016 and held it in 2 quarters.
  • IFC Holdings's PDL BioPharma, Inc. position peaked at $35K in Q4 2016.
  • 174 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2017.

Based on IFC Holdings's 13F filing for Q1 2017, filed 24 Apr 2017.